Search Within

Stephen Stacy Roberts

Formats
  1. Journal Article (52)
  2. Meeting Abstract (50)
  3. Review (2)
  4. Book Section (1)
  5. Correspondence (1)
  6. Editorial (1)
Groups
  1. Neuroblastoma Service (107)
  2. Pediatrics, Department of (107)
  3. GSK Faculty (74)
  4. Tow Center for Developmental Oncology (TCDO) (74)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (62)
  6. Center for Hematologic Malignancies (49)

More Groups

People
  1. Shakeel Modak (68)
  2. Ellen Basu (64)
  3. Brian Kushner (63)
  4. Nai-Kong Cheung (61)
  5. Kim Kramer (31)
  6. Audrey Mauguen (18)

More People

Years
  1. 2025 (1)
  2. 2023 (12)
  3. 2022 (7)
  4. 2021 (12)
  5. 2020 (13)
  6. 2019 (19)

More Years

Publications
  1. Pediatric Blood and Cancer (35)
  2. Journal of Clinical Oncology (10)
  3. Cancer Research (6)
  4. Neuro-Oncology (5)
  5. Cancer (4)
  6. International Journal of Cancer (4)

More Publications

Publishers
  1. Wiley Periodicals, Inc (36)
  2. American Society of Clinical Oncology (12)
  3. American Association for Cancer Research (9)
  4. Oxford University Press (6)
  5. Elsevier Inc. (5)
  6. Nature Publishing Group (5)

More Publishers

Results (107)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for consolidating >= 2nd complete remission of high-risk neuroblastoma
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Clinical impact of ALK mutations in neuroblastoma
    Meeting Abstract

    O'Donohue, T.; Gulati, N.; Shukla, N.; Roberts, S.; Basu, E.; Kushner, B.; Cheung, N. K.; Modak, S.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • A curative approach to central nervous system metastases of neuroblastoma
    Meeting Abstract

    Kramer, K.; Kushner, B.; Modak, S.; Pandit-Taskar, N.; Mauguen, A.; Tomlinson, U.; Wolden, S.; Zanzonico, P.; Humm, J.; Haque, S.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Naxitamab-based chemoimmunotherapy for resistant high-risk neuroblastoma: Preliminary results of "HITS" pilot/phase II study
    Meeting Abstract

    Modak, S.; Kushner, B.; Flores, M.; Santa-Maria, V.; Garraus, M.; Basu, E.; Roberts, S.; Castaneda, A.; Gorostegui, M.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Naxitamab-based chemoimmunotherapy for resistant high-risk neuroblastoma: Preliminary results of HITS pilot/phase II study
    Meeting Abstract

    Mora, J.; Kushner, B. H.; Flores, M. A.; Santa-Maria, V.; Garraus, M.; Basu, E. M.; Roberts, S. S.; Castaneda, A.; Gorostegui, M.; Cheung, N. K. V.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • High-dose naxitamab plus stepped-up dosing of GM-CSF for high-risk neuroblastoma (HR-NB): Efficacy against histologically-evident primary refractory metastases in bone marrow (BM)
    Meeting Abstract

    Kushner, B. H.; Modak, S.; Basu, E. M.; Roberts, S. S.; Cheung, N. K. V.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Effect of tandem autologous stem cell transplant vs single transplant on event-free survival in patients with high-risk neuroblastoma: A randomized clinical trial
    Journal Article

    Park, J. R.; Kreissman, S. G.; London, W. B.; Naranjo, A.; Lerner Cohn, S.; Hogarty, M. D.; Tenney, S. C.; Haas-Kogan, D.; Shaw, P. J.; Kraveka, J. M.; more...
    JAMA - Journal of the American Medical Association (2019)

    Fulltext@MSK | Save
  • Local anesthesia with general anesthesia for pediatric bone marrow procedures
    Journal Article

    Zarnegar-Lumley, S.; Lange, K. R.; Mathias, M. D.; Nakajima-Hatano, M.; Offer, K. M.; Ogu, U. O.; Ortiz, M. V.; Tan, K. S.; Kellick, M.; Modak, S.; more...
    Pediatrics (2019)

    Fulltext@MSK | Save
  • ATRX in-frame fusion neuroblastoma is sensitive to EZH2 inhibition via modulation of neuronal gene signatures
    Meeting Abstract

    Qadeer, Z.; Valle-Garcia, D.; Hasson, D.; Soriano, A.; Ma, A.; Griffiths, L.; Zeineldin, M.; Sun, Z.; Jubierre, L.; Filipescu, D.; more...
    Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • Reduced-dose radiation therapy to the primary site is effective for high-risk neuroblastoma: Results from a prospective trial
    Journal Article

    Casey, D. L.; Kushner, B. H.; Cheung, N. K. V.; Modak, S.; Basu, E. M.; Roberts, S. S.; LaQuaglia, M. P.; Wolden, S. L.
    International Journal of Radiation Oncology, Biology, Physics (2019)

    Fulltext@MSK | Save